Update to US Selected Practice Recommendations for Contraceptive Use: Self-Administration of Subcutaneous Depot Medroxyprogesterone Acetate

被引：0
|
作者：
Curtis, Kathryn M. [1 ]
Nguyen, Antoinette [1 ]
Reeves, Jennifer A. [1 ]
Clark, Elizabeth A. [1 ]
Bolger, Suzanne G. [1 ]
Whiteman, Maura K. [1 ]
机构：
[1] CDC, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Reprod Hlth, Atlanta, GA 30333 USA
来源：
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT | 2021年 / 70卷 / 20期
关键词：
TRIAL;
D O I：
10.15585/mmwr.mm7020a2
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
[No abstract available]
引用
收藏
页码：739 / 743
页数：5
相关论文
共 50 条
  • [31] SELF VERSUS CLINIC ADMINISTRATION OF DEPOT MEDROXYPROGESTERONE ACETATE (DMPA): A RANDOMIZED CLINICAL TRIAL
    Beasley, A.
    White, K.
    Westhoff, C.
    CONTRACEPTION, 2012, 86 (03) : 315 - 315
  • [32] Suppression of ovulation by a new subcutaneous depot medroxyprogesterone acetate (104 mg/0.65 mL) contraceptive formulation in Asian women
    Toll, YC
    Jain, J
    Rahimy, MH
    Bode, FR
    Ross, D
    CLINICAL THERAPEUTICS, 2004, 26 (11) : 1845 - 1854
  • [33] 2016 Updates to US Medical Eligibility Criteria for Contraceptive Use and Selected Practice Recommendations for Contraceptive Use: Highlights for Adolescent Patients
    Hoopes, Andrea J.
    Simmons, Katharine B.
    Godfrey, Emily M.
    Sucato, Gina S.
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2017, 30 (02) : 149 - 155
  • [34] Effect of timing of postpartum depot medroxyprogesterone acetate initiation on breastfeeding continuation and contraceptive use: a randomized trial
    Chen, B. A.
    Haddad, L. B.
    Achilles, S. L.
    Cordes, S. M. D.
    Schwarz, E. B.
    CONTRACEPTION, 2017, 96 (04) : 278 - 279
  • [35] Hyperinsulinemic-euglycemic clamp over the first year of use of depot-medroxyprogesterone acetate as a contraceptive
    Melhado-Kimura, Vaneska
    Batista, Gisele Almeida
    de Souza, Aglecio Luiz
    Silva dos Santos, Priscilla de Nazare
    Alegre, Sarah Monte
    Pavin, Elizabeth Joao
    Bahamondes, Luis
    Fernandes, Arlete
    CONTRACEPTION, 2018, 98 (02) : 144 - 150
  • [36] Insulin resistance parameters in users of the injectable contraceptive depot medroxyprogesterone acetate during one year of use
    Cursino, Kleber
    Sider, Marina
    Pavin, Elizabeth Joao
    Silva dos Santos, Priscilla de Nazare
    Bahamondes, Luis
    Zantut-Wittmann, Denise Engelbrecht
    Fernandes, Arlete
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2016, 21 (01): : 22 - 29
  • [37] Research gaps identified during the 2014 update of the WHO medical eligibility criteria for contraceptive use and selected practice recommendations for contraceptive use
    Dragoman, Monica V.
    Jatlaoui, Tara
    Nanda, Kavita
    Curtis, Kathryn M.
    Gaffield, Mary E.
    CONTRACEPTION, 2016, 94 (03) : 195 - 201
  • [38] "IT WOULD PUT IT IN THEIR OWN HANDS": HEALTHCARE PROVIDERS' PERSPECTIVES TOWARDS PATIENT SELF-ADMINISTRATION OF SUBCUTANEOUS MEDROXYPROGESTERONE ACETATE (DMPA-SC)
    Lawal, F. B.
    Hubach, R. D.
    LaRoche, K. J.
    CONTRACEPTION, 2023, 127 : 33 - 33
  • [39] Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?
    Polis, Chelsea B.
    Achilles, Sharon L.
    Hel, Zdenek
    Hapgood, Janet P.
    CONTRACEPTION, 2018, 97 (03) : 191 - 197
  • [40] Serum immunoglobulin levels during contraceptive use of depot-medroxyprogesterone acetate in Indian women: A preliminary study
    Lali, P
    Chandra, L
    Gupta, RP
    CONTRACEPTION, 1996, 53 (06) : 363 - 365
12345